FDA Approves New Drug to Prevent RSV in Babies and Toddlers
The FDA approved the first drug for the prevention of RSV lower respiratory tract disease in babies and toddlers.
Related Articles
Scientists spot an orangutan using a plant to treat his own wound in the wild
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
Scientists spot an orangutan using a plant to treat his own wound in the wild
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
Lawmakers, as part of ‘lab leak’ Covid inquiry, press to bar EcoHealth from federal research funds
A House subcommittee investigating the “lab leak” theory of Covid origins accuses EcoHealth of misrepresenting its virus research in Wuhan and pushes to deny it…
Scientists spot an orangutan using a plant to treat his own wound in the wild
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
Change Healthcare Finally Admits It Paid Ransomware Hackers—and Still Faces a Patient Data Leak
The company belatedly conceded both that it had paid the cybercriminals extorting it and that patient data nonetheless ended up on the dark web.
DEA reverses a policy to avert morphine shortages
The DEA is allowing annual and semi-annual production quotas for Schedule II drugs, after it became clear quarterly quotas would worsen shortages.
Moderna ends collaboration with CRISPR company Metagenomi, parts ways with gene editing chief
Three years ago, Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it’s backing out.
After private equity firms gobbled up wheelchair makers, users pay the price in long repair times
Over the last decade, private equity firms acquired scores of wheelchair makers. Now, users routinely wait months to get their chairs repaired.
Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.